JustPharmaReports.com Research Reports

Title	Published	Price
Distribution and Patient Support for Speciality Medicines in Europe By: JustPharmaReports.com Speciality medicines (specialty in the US) have become one of the main drivers of pharmaceutical industry growth. High tech, ‘high touch’ products with premium prices targeted at chronic, complex diseases, often requiring special storage and \| more... Search inside this report	9/1/2009	$1,050.00
Prospects for Legalizing Drug (Re-)Importation to the United States By: JustPharmaReports.com President Barack Obama said during his election campaign he would ‘allow Americans to buy their medicines from other developed countries if the drugs are safe and prices are lower outside the US’. He began delivering \| more... Search inside this report	6/1/2009	$1,600.00
Complete Guide to the 2009 PPRS, NICE & other Pharmaceutical Cost Containment Measures in the United Kingdom By: JustPharmaReports.com In an otherwise volatile pharmaceutical world, 2009 has seen two notable and durable anniversaries, the implementation of the tenth re-negotiated Pharmaceutical Price Regulation Scheme in January and the tenth birthday of the National Institute for \| more... Search inside this report	4/1/2009	$1,350.00
Pharmacy Liberalisation in Europe: Prospects and Implications By: JustPharmaReports.com Very little in the pricing environment in Europe is predictable to pharmaceutical companies and only rarely is much notice given of change. But before the end of 2009, if the European Court of Justice accepts \| more...	9/1/2008	$905.00
Access to Hospital Pharmaceutical Markets in the United Kingdom By: JustPharmaReports.com Public hospitals represent a very important market segment for most biopharmaceutical companies in Europe. They are the often the only market for the increasing numbers of speciality drugs emerging from R&D, with many primary care \| more... Search inside this report	8/1/2008	$1,350.00
Pharmaceutical Pricing and Distribution in Japan: The Keys to Success in the World’s Second Largest Market By: JustPharmaReports.com No serious multinational can afford to ignore Japan, but it remains a tough and highly competitive market to crack, with the environment for developing and marketing medicines dominated by price. Virtually no new prescription brand \| more... Search inside this report	6/1/2008	$2,700.00
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues By: JustPharmaReports.com In order to raise public awareness, 29 February 2008 was dedicated the first European rare disease day (‘a rare day for very special people’), but European payers need no reminding of the significance of rare \| more... Search inside this report	4/1/2008	$2,700.00
Title	Published	Price

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/21/2009 - 2